Immune thrombocytopenia (ITP) is an entity characterized by a platelet count of less than 100 × 109/L in the absence of other causes of thrombocytopenia, such as viral infections, rheumatic diseases, or drugs. Grave’s disease is also an autoimmune condition in which thrombocytopenia is often observed. Moreover, in the literature, many reports show a marked interference of the thyroid dysfunction (mainly hyperthyroidism) in the control of thrombocytopenia. Although this issue still remains debatable, the authors report the case of a young woman with a previous diagnosis of ITP with a brilliant initial response to corticotherapy. Some years after this diagnosis, the patient presented thyrotoxicosis due to Grave’s disease and the thrombocytopenia relapsed, but this time there was no response to the glucocorticoids. Only after the radioiodine I-131 thyroid ablation the control of thrombocytopenia was achieved. The authors call attention to this overlap and for testing thyroid function in every patient with an unexpected negative response to corticotherapy.
NeunertC, LimW, CrowtherM, CohenA, SolbergLJr, CrowtherMA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190-207. [https://doi.org/10.1182/blood-2010-08-302984]. [PMID:21325604]
JacksonAS. Acute hemorrhagic purpura associated with exophthalmic goiter. JAMA. 1931;113:2386-93.
MarshallJS, WeisbergerAS, LevyRP, BreckenridgeRT. Coexistent Idiopathic Thrombocytopenic Purpura and Hyperthyroidism. Ann Intern Med. 1967;67(2):411-4. [https://doi.org/10.7326/0003-4819-67-2-411].
GillH, HwangYY, TseE. Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves’ disease. Ann Hematol. 2011;90(2):223-4. [https://doi.org/10.1007/s00277-010-0983-4]. [PMID:20467745]
PavithranK, SreekumarA, KrishnamohanVE. Idiopathic thrombocytopenic purpura associated with Graves’ disease--case report. Indian J Med Sci. 1996;50(2):43-6. [PMID:8979632]
KurataY. NIshioeda Y, Tsubasio T, KitaninT. Thrombocytopenia in Grave’s disease: effect of T3 on platelet kinetics. Acta Hematolol. 1980;63:185-90. [https://doi.org/10.1159/000207396].
GrumetFC, PayneRO, KonishiJ, KrissJP. HL-A antigens as markers for disease susceptibility and autoimmunity in Graves’ disease. J Clin Endocrinol Metab. 1974;39(6):1115-9. [https://doi.org/10.1210/jcem-39-6-1115]. [PMID:4479624]
VergèsB, Giroud-BaleydierF, OlssonO, VaillantG, BrunJM, PutelatR. [Association of Basedow’s disease and autoimmune thrombopenic purpura. No effect of hyperthyroidism on antiplatelet autoimmunity]. Rev Med Interne. 1989;10(6):565-9. [PMID:2488511]
Cohen AubartF, JublancC, BruckertE. [Graves’ disease and autoimmune thrombocytopenic purpura: distinct outcomes of the two diseases]. Ann Endocrinol. 2007;68(1):55-7. [https://doi.org/10.1016/j.ando.2006.12.001]. [PMID:17292844]
AltintasA, PasaS, CilT, BayanK, GokalpD, AyyildizO. Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura. Platelets. 2008;19(4):252-7. [https://doi.org/10.1080/09537100801894651]. [PMID:18569860]
LeedmanPJ, Faulkner-JonesB, CramDS, et al. Cloning from the thyroid of a protein related to actin binding protein that is recognized by Graves disease immunoglobulins. Proc Natl Acad Sci USA. 1993;90(13):5994-8. [https://doi.org/10.1073/pnas.90.13.5994]. [PMID:8327473]
JungRS, ParghaneRV, SoodA, BhattacharyaA, MittalBR. Primary autoimmune thrombocytopenia and co-existing Graves’ disease: Role of radioiodine-131. Indian J Nucl Med. 2014;29(3):195-6. [https://doi.org/10.4103/0972-3919.136602]. [PMID:25210295]
HermanJ, ResnitzkyP, FinkA. Association between thyrotoxicosis and thrombocytopenia. A case report and review of the literature. Isr J Med Sci. 1978;14(4):469-75. [PMID:566733]
ProvanD, StasiR, NewlandAC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168-86. [https://doi.org/10.1182/blood-2009-06-225565]. [PMID:19846889]